Press Release

Endocrine Society encouraged by Lilly’s new lower-priced insulin

Washington, DC May 22, 2019

Eli Lilly and Company recently announced its authorized generic version of lispro is now available at a 50 percent lower list price than the brand name version, Humalog U-100. The Society is pleased at this step toward improving access to affordable insulin. According to a press release from the company, the generic lispro can now be ordered in pharmacies. This announcement is welcome news for patients who are currently paying out of pocket for Humalog U-100. According to Lilly, some insurers will be including generic lispro on their formularies.

For patients who wish to change to the generic version of lispro, prescribers should write for lispro insulin, rather than Humalog. Patients with questions about generic lispro and insulin affordability can contact the Lilly Diabetes Solution Center at (833) 808-1234.

The Endocrine Society continues to urge policymakers, drug manufacturers, insurance companies and pharmacy benefit managers to work together to stop the spiraling cost of insulin and other medications that has led to an ever-growing patchwork of complex, confusing, and difficult to access safety net programs.


MEDIA CONTACTS

Jenni Glenn Gingery
Associate Director, Communications and Media Relations
[email protected] | 202-971-3655

Colleen M. Williams
Manager Public Relations 
[email protected] | 202-971-3611

Follow us on Twitter at @TheEndoSociety and @EndoMedia.

 

Media Contacts

Colleen Williams Manager, Public Relations Phone: (202)-971-3611 [email protected]

Jenni Glenn Gingery Associate Director, Communications and Media Relations Phone: (202)-971-3655 [email protected]

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!